Combretastatin A-4 (CA-4), a natural vascular disrupting agent (VDA) with potent anti-cancer activity, is a promising lead compound in drug discovery. In view of the potential application of carbohydrates in medicinal chemistry, we designed and synthesized sixteen novel CA-4 aminosaccharide derivatives. In vitro anti-proliferative studies showed that compounds 7a and 7c significantly inhibited the growth of human umbilical vein endothelia cells (HUVEC) and other four cancer cell lines. Besides, preliminary structure-activity relationship (SAR) was summarized.
Keywords: Anti-cancer agent, Aminosaccharide, Combretastatin A-4 (CA-4), Vascular disrupting agent (VDA), Structural
modification, Human umbilical vein endothelia cells (HUVEC).
Rights & PermissionsPrintExport
Published on: 24 October, 2013
Page: [935 - 941]